Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taliglucerase alfa in pediatric Gaucher disease
NCT01132690Phase 4Completed
- Sponsor
- Pfizer
- Start
- Aug 2010
- Primary completion
- May 2012
- Modality
- Replacement Enzymes
- Countries
- 3
01
Overview
A Phase 4 trial of taliglucerase alfa in Gaucher disease (GD), sponsored by Pfizer. Started Aug 2010; status: completed.
02
Drugs
taliglucerase alfa
03
Conditions
Gaucher disease (GD)
Beyond the preview
Go deeper on NCT01132690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01132690.